First Time Loading...

Valeo Pharma Inc
TSX:VPH

Watchlist Manager
Valeo Pharma Inc Logo
Valeo Pharma Inc
TSX:VPH
Watchlist
Price: 0.105 CAD 5%
Updated: May 21, 2024

Gross Margin
Valeo Pharma Inc

21.4%
Current
27%
Average
36.7%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
21.4%
=
Gross Profit
11.6m
/
Revenue
54.3m

Gross Margin Across Competitors

Country Company Market Cap Gross
Margin
CA
Valeo Pharma Inc
TSX:VPH
10.4m CAD
21%
CA
Advance Lithium Corp
XTSX:AALI
517.8B CAD N/A
US
Gould Investors LP
OTC:GDVTZ
303.5B USD N/A
US
Carson Energy Development Corp
OTC:CDVM
270.6B USD
10%
NL
Nepi Rockcastle NV
JSE:NRP
77.4B Zac
64%
US
Liberty Bancshares Inc
OTC:LBSI
55.5B USD N/A
US
Ergo Science Corp
OTC:ERGN
55.2B USD
32%
US
HK Graphene Technology Corp
OTC:HKGT
53.9B USD N/A
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
765.1T IDR
58%
US
GE Vernova LLC
NYSE:GEV
43.8B USD
15%
US
Coupang Inc
F:788
38.4B EUR
26%
Valeo Pharma Inc
TSX:VPH
Country CA
Market Cap 10.4m CAD
Gross Margin
21%
A
Advance Lithium Corp
XTSX:AALI
Country CA
Market Cap 517.8B CAD
Gross Margin N/A
G
Gould Investors LP
OTC:GDVTZ
Country US
Market Cap 303.5B USD
Gross Margin N/A
C
Carson Energy Development Corp
OTC:CDVM
Country US
Market Cap 270.6B USD
Gross Margin
10%
N
Nepi Rockcastle NV
JSE:NRP
Country NL
Market Cap 77.4B Zac
Gross Margin
64%
Liberty Bancshares Inc
OTC:LBSI
Country US
Market Cap 55.5B USD
Gross Margin N/A
Ergo Science Corp
OTC:ERGN
Country US
Market Cap 55.2B USD
Gross Margin
32%
H
HK Graphene Technology Corp
OTC:HKGT
Country US
Market Cap 53.9B USD
Gross Margin N/A
Amman Mineral Internasional Tbk PT
IDX:AMMN
Country ID
Market Cap 765.1T IDR
Gross Margin
58%
G
GE Vernova LLC
NYSE:GEV
Country US
Market Cap 43.8B USD
Gross Margin
15%
Coupang Inc
F:788
Country US
Market Cap 38.4B EUR
Gross Margin
26%

Profitability Report

View the profitability report to see the full profitability analysis for Valeo Pharma Inc.

Full Profitability Report

See Also

Summary
VPH intrinsic value, competitors valuation, and company profile.
DCF Valuation
VPH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
VPH stock valuation using valuation multiples.
Wall Street Estimates
VPH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
VPH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
21.4%
=
Gross Profit
11.6m
/
Revenue
54.3m
What is the Gross Margin of Valeo Pharma Inc?

Based on Valeo Pharma Inc's most recent financial statements, the company has Gross Margin of 21.4%.

ALPHA SPREAD
Join more than 139,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.